choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Viiv Healthcare

Viiv Healthcare Newsletter
  • Shionogi Expands Stake in ViiV Healthcare After Pfizer Exit 22 Jan 2026 20:44 GMT

    … Pfizer Inc., to reshape the ownership structure of ViiV Healthcare, the global specialist HIV … economic interest in ViiV Healthcare to 21.7%, while GSK will retain its … in 2009 alongside GSK. As part of the deal, ViiV Healthcare will issue …

  • <![CDATA[Shionogi Acquires $2.1 Billion ViiV Healthcare Shareholdings from Pfizer ]]> 21 Jan 2026 02:09 GMT

    … deeper and broader interest in HIV and AIDS while also taking a … Shionogi. GSK, Pfizer and Shionogi Agree on Changes to ViiV Healthcare Shareholding ViiV Healthcare January 20 …

  • GSK and Shionogi agree to replace Pfizer's stake in ViiV Healthcare 21 Jan 2026 07:55 GMT

    … in ViiV Healthcare. Pfizer will receive $1.875 billion and GSK will … in GBP). ViiV Healthcare, the global specialist HIV company, is dedicated … infectious diseases, with HIV being one of our … ongoing HIV research continues to contribute to ViiV’s pipeline …

  • Shionogi expands ViiV Healthcare stake by $2.13bn as Pfizer sells up 20 Jan 2026 19:16 GMT

    … virus (HIV) medicines developer in a $2.13bn deal. ViiV Healthcare, which … on 19 January. ViiV Healthcare was established by Pfizer and GSK in a bid … (maraviroc). ViiV Healthcare’s current product portfolio consists of 15 prescription HIV medicines …

  • ViiV ownership shifts as Pfizer sells its stake 20 Jan 2026 17:27 GMT

    Pfizer will relinquish its stake in ViiV Healthcare in a deal valued … the HIV specialist. Under the terms of the deal, GSK retains … our strategic partnership with GSK and ViiV through this agreement, … revenues to GSK, with sales of its HIV therapies reaching …

  • Pfizer Pockets $1.9B by Offloading Stake in HIV Drugs Company Majority Owned by GSK 22 Jan 2026 00:20 GMT

    … a portfolio of 10 HIV medicines from GSK and Pfizer along with plans … . At the time, GSK owned 85% of ViiV and Pfizer owned 15%. In … injectable HIV treatment and prevention medicines,” David Redfern, chair of ViiV Healthcare, said …

  • Pfizer to exit ViiV Healthcare in $1.9 bn deal 20 Jan 2026 13:39 GMT

    … on Tuesday ‌that Pfizer ‌will exit their HIV specialist ViiV Healthcare in a deal … ​majority holding in the global HIV company. Pfizer in ​December had warned … . drugmaker's ‍shares. GSK established ⁠ViiV Healthcare with ⁠Pfizer in 2009, with Shionogi …

  • Japan's Shionogi pays $2.13B to boost stake in ViiV Healthcare 20 Jan 2026 08:44 GMT

    … with British drugmaker GSK, raising its stake in the HIV drugmaker to … Pfizer’s shares. GSK will retain its 78.3% majority stake in ViiV Healthcare … pipeline of long-acting injectable ⁠HIV treatments and prevention medicines. News …

  • GSK, Pfizer and Shionogi agree on changes to ViiV Healthcare shareholding 20 Jan 2026 07:13 GMT

    … holding in ViiV Healthcare. Pfizer will receive $1.875 bn and GSK will receive … (payable in GBP). ViiV Healthcare, the global specialist HIV company, is dedicated to … could benefit from HIV prevention. . David Redfern, Chair of ViiV Healthcare said: “This …

  • How community-led HIV programme transforms care for children, adolescents in Taraba 21 Jan 2026 06:09 GMT

    … ViiV Healthcare’s Positive Action programme, has recorded significant improvements in HIV … tools and job aids were reproduced and … , and stigma-free HIV services. The intervention directly … the Control of AIDS (TACA), Local AIDS Control Agencies (LACA …

Satisfied with the content?

Continue to create your account.